These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8081252)
1. GPI-specific phospholipase D as an apolipoprotein. Deeg MA Braz J Med Biol Res; 1994 Feb; 27(2):375-81. PubMed ID: 8081252 [TBL] [Abstract][Full Text] [Related]
2. GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. Deeg MA; Bierman EL; Cheung MC J Lipid Res; 2001 Mar; 42(3):442-51. PubMed ID: 11254757 [TBL] [Abstract][Full Text] [Related]
3. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux. Cheung MC; Mendez AJ; Wolf AC; Knopp RH J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861 [TBL] [Abstract][Full Text] [Related]
4. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma. Cheung MC; Wolf AC; Illingworth DR Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles. Hennessy LK; Kunitake ST; Kane JP Biochemistry; 1993 Jun; 32(22):5759-65. PubMed ID: 8504094 [TBL] [Abstract][Full Text] [Related]
6. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma. Nichols AV; Blanche PJ; Shore VG; Gong EL Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827 [TBL] [Abstract][Full Text] [Related]
7. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Raikwar NS; Cho WK; Bowen RF; Deeg MA Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662 [TBL] [Abstract][Full Text] [Related]
8. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol. Sakai T; Kamanna VS; Kashyap ML Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466 [TBL] [Abstract][Full Text] [Related]
9. Concentrations of apolipoprotein AI, AII, and E in plasma and lipoprotein fractions of alcoholic patients: gender differences in the effects of alcohol. Lin RC; Miller BA; Kelly TJ Hepatology; 1995 Apr; 21(4):942-9. PubMed ID: 7705804 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D. Deeg MA; Bowen RF Biochem Cell Biol; 2002; 80(2):253-60. PubMed ID: 11989719 [TBL] [Abstract][Full Text] [Related]
11. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II. Cheung MC; Wolf AC; Knopp RH; Foster DM Biochim Biophys Acta; 1992 Nov; 1165(1):68-77. PubMed ID: 1420350 [TBL] [Abstract][Full Text] [Related]
12. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. Cheung MC; Brown BG; Wolf AC; Albers JJ J Lipid Res; 1991 Mar; 32(3):383-94. PubMed ID: 1906084 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional assessment of high-density lipoprotein heterogeneity. Dobiásová M; Frohlich JJ Clin Chem; 1994 Aug; 40(8):1554-8. PubMed ID: 8044996 [TBL] [Abstract][Full Text] [Related]
15. Genetic variation of GPLD1 associates with serum GPI-PLD levels: a preliminary study. Deeg MA; Xuei X; Eckert G; Considine RV; Li YG; Pratt JH Biochim Biophys Acta; 2012 Mar; 1821(3):381-5. PubMed ID: 22260953 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]
17. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. Cheung MC; Albers JJ J Biol Chem; 1984 Oct; 259(19):12201-9. PubMed ID: 6434538 [TBL] [Abstract][Full Text] [Related]
18. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. James RW; Proudfoot A; Pometta D Biochim Biophys Acta; 1989 Apr; 1002(3):292-301. PubMed ID: 2469471 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. Johnson WJ; Kilsdonk EP; van Tol A; Phillips MC; Rothblat GH J Lipid Res; 1991 Dec; 32(12):1993-2000. PubMed ID: 1816327 [TBL] [Abstract][Full Text] [Related]
20. Characterization of lipoproteins containing a truncated form of apolipoprotein B, apolipoprotein B32. McCormick SP; Day WA; George PM Biochim Biophys Acta; 1995 Aug; 1258(1):49-56. PubMed ID: 7654780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]